View in EDS HTML Full Text PDF Full Text

Characterization of Patients with EGFR Mutation-Positive NSCLC Following Emergence of the Osimertinib Resistance Mutations, L718Q or G724S: A Multicenter Retrospective Observational Study in France.

Saved in:
Bibliographic Details
Title: Characterization of Patients with EGFR Mutation-Positive NSCLC Following Emergence of the Osimertinib Resistance Mutations, L718Q or G724S: A Multicenter Retrospective Observational Study in France.
Authors: Sanchis-Borja M; Pulmonology Department, Créteil Intercommunal Hospital, Créteil, France., Guisier F; Normandie Univ, UNIROUEN, LITIS Laboratory QuantIF team EA4108, CHU Rouen, Department of Pneumology and Inserm CIC-CRB 1404, Rouen, France., Swalduz A; Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France., Curcio H; Department of Medical Oncology, Centre François Baclesse, Caen, France., Basse V; Centre Oncologie Saint Yves, Vannes, France., Maritaz C; Medical Affairs Department, Oncology, Boehringer Ingelheim France, Paris, France., Chouaid C; Pulmonology Department, Créteil Intercommunal Hospital, Créteil, France., Auliac JB; Pulmonology Department, Créteil Intercommunal Hospital, Créteil, France.
Source: OncoTargets and therapy [Onco Targets Ther] 2024 May 29; Vol. 17, pp. 439-448. Date of Electronic Publication: 2024 May 29 (Print Publication: 2024).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101514322 Publication Model: eCollection Cited Medium: Print ISSN: 1178-6930 (Print) Linking ISSN: 11786930 NLM ISO Abbreviation: Onco Targets Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38836187
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Characterization of Patients with EGFR Mutation-Positive NSCLC Following Emergence of the Osimertinib Resistance Mutations, L718Q or G724S: A Multicenter Retrospective Observational Study in France.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sanchis-Borja+M%22">Sanchis-Borja M</searchLink>; Pulmonology Department, Créteil Intercommunal Hospital, Créteil, France.<br /><searchLink fieldCode="AU" term="%22Guisier+F%22">Guisier F</searchLink>; Normandie Univ, UNIROUEN, LITIS Laboratory QuantIF team EA4108, CHU Rouen, Department of Pneumology and Inserm CIC-CRB 1404, Rouen, France.<br /><searchLink fieldCode="AU" term="%22Swalduz+A%22">Swalduz A</searchLink>; Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Curcio+H%22">Curcio H</searchLink>; Department of Medical Oncology, Centre François Baclesse, Caen, France.<br /><searchLink fieldCode="AU" term="%22Basse+V%22">Basse V</searchLink>; Centre Oncologie Saint Yves, Vannes, France.<br /><searchLink fieldCode="AU" term="%22Maritaz+C%22">Maritaz C</searchLink>; Medical Affairs Department, Oncology, Boehringer Ingelheim France, Paris, France.<br /><searchLink fieldCode="AU" term="%22Chouaid+C%22">Chouaid C</searchLink>; Pulmonology Department, Créteil Intercommunal Hospital, Créteil, France.<br /><searchLink fieldCode="AU" term="%22Auliac+JB%22">Auliac JB</searchLink>; Pulmonology Department, Créteil Intercommunal Hospital, Créteil, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101514322%22">OncoTargets and therapy</searchLink> [Onco Targets Ther] 2024 May 29; Vol. 17, pp. 439-448. <i>Date of Electronic Publication: </i>2024 May 29 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Dove+Medical+Press%22">Dove Medical Press </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101514322 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1178-6930 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211786930%22">11786930 </searchLink><i>NLM ISO Abbreviation: </i>Onco Targets Ther <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38836187
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2147/OTT.S448909
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 439
    Titles:
      – TitleFull: Characterization of Patients with EGFR Mutation-Positive NSCLC Following Emergence of the Osimertinib Resistance Mutations, L718Q or G724S: A Multicenter Retrospective Observational Study in France.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sanchis-Borja M
      – PersonEntity:
          Name:
            NameFull: Guisier F
      – PersonEntity:
          Name:
            NameFull: Swalduz A
      – PersonEntity:
          Name:
            NameFull: Curcio H
      – PersonEntity:
          Name:
            NameFull: Basse V
      – PersonEntity:
          Name:
            NameFull: Maritaz C
      – PersonEntity:
          Name:
            NameFull: Chouaid C
      – PersonEntity:
          Name:
            NameFull: Auliac JB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 05
              Text: 2024 May 29
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 1178-6930
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: OncoTargets and therapy
              Type: main
ResultId 1